Joey Hamilton, MD
Family Medicine · Carrollton, TXNPI 1386620946
Payments from drug & device makers
Across 184 payments — averaging $17.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$526
- Abbott$485
- AstraZeneca$300
- Gilead$244
- GSK$160
- Lilly USA, LLC$158
- plus $1K from 32 others
What the payments were for
- Food & beverage$3,138100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 31 | $526 |
| Abbott | 25 | $485 |
| AstraZeneca | 21 | $300 |
| Gilead | 14 | $244 |
| GSK | 11 | $160 |
| Lilly USA, LLC | 11 | $158 |
| Amarin Pharma, Inc. | 9 | $144 |
| Genentech USA, Inc. | 6 | $107 |
| Pfizer | 5 | $80 |
| Cleerly, Inc. | 1 | $72 |
| Biotronik NRO, Inc. | 1 | $64 |
| Novo Nordisk | 4 | $60 |
| Azurity Pharmaceuticals, Inc. | 3 | $52 |
| Exact Sciences | 3 | $45 |
| Boston Scientific | 2 | $44 |
| Corium, LLC | 2 | $44 |
| Teva Pharmaceuticals USA, Inc. | 2 | $42 |
| Boehringer Ingelheim | 2 | $39 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $33 |
| Antares Pharma, Inc. | 2 | $32 |
| Astellas Pharma US Inc | 2 | $32 |
| Medtronic | 2 | $31 |
| Sanofi-aventis U.S. LLC | 2 | $31 |
| Idorsia Pharmaceuticals US Inc | 2 | $30 |
| Jazz Pharmaceuticals Inc. | 2 | $29 |
| Amgen | 2 | $29 |
| Nalpropion Pharmaceuticals LLC | 2 | $23 |
| Merck | 2 | $23 |
| Philips North America LLC | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Sanofi Pasteur Inc. | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| Lundbeck LLC | 1 | $13 |
| Shire North American Group Inc | 1 | $13 |
How this compares
$3,138 in reported general payments places this provider in the 80th percentile of 8,760 family medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 25 | $23,418 |
| MounjaroTirzepatide | 12 | $10,800 |
| Atorvastatin Calcium | 165 | $1,298 |
| Levothyroxine Sodium | 105 | $1,290 |
| Rosuvastatin Calcium | 74 | $617 |
| Metoprolol Succinate | 36 | $604 |
| Lisinopril | 117 | $538 |
| Pravastatin Sodium | 47 | $511 |
| Metformin Hcl ErMetformin Hcl | 35 | $488 |
| Omeprazole | 34 | $417 |
| Glipizide ErGlipizide | 22 | $397 |
| Allopurinol | 22 | $392 |
| Amitriptyline Hcl | 11 | $353 |
| Metformin Hcl | 31 | $348 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 15 | $346 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $60 | $23,41825 claims |
| Lilly USA, LLCMounjaro | $158 | $10,80012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Carrollton
- Jeffrey StewartCarrollton$5.7M
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
- Veronica FragosoHouston$24.5M
- Joel SolisMcAllen$21.1M
- George AtieeSan Antonio$19.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.